Victorino 2015 Tumour Biol: Difference between revisions

From Bioblast
No edit summary
No edit summary
Line 6: Line 6:
|journal=Tumour Biol
|journal=Tumour Biol
|abstract=Breast cancer is a prevalent neoplastic disease among women worldwide which treatments still present several side effects and resistance. Considering that cancer cells present derangements in their energetic homeostasis, and that peroxisome proliferator-activated receptor- gamma coactivator 1 (PGC-1) is crucial for cellular metabolism and redox signaling, the main objective of this study was to investigate whether there is a relationship between PGC-1 expression, the proliferation of breast cancer cells and the mechanisms involved. We initially assessed PGC-1Ξ² expression in complementary DNA (cDNA) from breast tumor of patients bearing luminal A, luminal B, and HER2-overexpressed and triple negative tumors. Our data showed that PGC-1Ξ² expression is increased in patients bearing HER2-overexpressing tumors as compared to others subtypes. Using quantitative PCR and immunoblotting, we showed that breast cancer cells with HER2-amplification (SKBR-3) have greater expression of PGC-1Ξ² as compared to a non-tumorous breast cell (MCF-10A) and higher proliferation rate. PGC-1Ξ² expression was knocked down with short interfering RNA in HER2-overexpressing cells, and cells decreased proliferation. In these PGC-1Ξ²-inhibited cells, we found increased citrate synthase activity and no marked changes in mitochondrial respiration. Glycolytic pathway was decreased, characterized by lower intracellular lactate levels. In addition, after PGC-1Ξ² knockdown, SKBR-3 cells showed increased reactive oxygen species production, no changes in antioxidant activity, and decreased expression of ERRΞ±, a modulator of metabolism. In conclusion, we show an association of HER2-overexpression and PGC-1Ξ². PGC-1Ξ² knockdown impairs HER2-overexpressing cells proliferation acting on ERRΞ± signaling, metabolism, and redox balance.
|abstract=Breast cancer is a prevalent neoplastic disease among women worldwide which treatments still present several side effects and resistance. Considering that cancer cells present derangements in their energetic homeostasis, and that peroxisome proliferator-activated receptor- gamma coactivator 1 (PGC-1) is crucial for cellular metabolism and redox signaling, the main objective of this study was to investigate whether there is a relationship between PGC-1 expression, the proliferation of breast cancer cells and the mechanisms involved. We initially assessed PGC-1Ξ² expression in complementary DNA (cDNA) from breast tumor of patients bearing luminal A, luminal B, and HER2-overexpressed and triple negative tumors. Our data showed that PGC-1Ξ² expression is increased in patients bearing HER2-overexpressing tumors as compared to others subtypes. Using quantitative PCR and immunoblotting, we showed that breast cancer cells with HER2-amplification (SKBR-3) have greater expression of PGC-1Ξ² as compared to a non-tumorous breast cell (MCF-10A) and higher proliferation rate. PGC-1Ξ² expression was knocked down with short interfering RNA in HER2-overexpressing cells, and cells decreased proliferation. In these PGC-1Ξ²-inhibited cells, we found increased citrate synthase activity and no marked changes in mitochondrial respiration. Glycolytic pathway was decreased, characterized by lower intracellular lactate levels. In addition, after PGC-1Ξ² knockdown, SKBR-3 cells showed increased reactive oxygen species production, no changes in antioxidant activity, and decreased expression of ERRΞ±, a modulator of metabolism. In conclusion, we show an association of HER2-overexpression and PGC-1Ξ². PGC-1Ξ² knockdown impairs HER2-overexpressing cells proliferation acting on ERRΞ± signaling, metabolism, and redox balance.
|keywords=Breast cancer subtypes, HER2-overexpressing, PGC-1Ξ², Proliferation
|keywords=Breast cancer subtypes, HER2-overexpressing, PGC-1Ξ², Proliferation, Human breast adenocarcinoma SKBR-3 cells
}}
}}
{{Labeling
{{Labeling
Line 15: Line 15:
|preparations=Intact cells
|preparations=Intact cells
|diseases=Cancer
|diseases=Cancer
|couplingstates=LEAK, OXPHOS, ETS
|couplingstates=LEAK, ROUTINE, ETS
|substratestates=ROX
|substratestates=ROX
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|additional=Labels, [Epub ahead of print], 2016-01
|additional=[Epub ahead of print], 2016-01
}}
}}

Revision as of 15:55, 22 March 2016

Publications in the MiPMap
[[Has title::Victorino VJ, Barroso WA, Assunção AK, Cury V, Jeremias IC, Petroni R, Chausse B, Ariga SK, Herrera AC, Panis C, Lima TM, Souza HP (2015) PGC-1β regulates HER2-overexpressing breast cancer cells proliferation by metabolic and redox pathways. Tumour Biol [Epub ahead of print].]]

Β» [[Has info::PMID: 26602383]]

Victorino VJ, Barroso WA, Assuncao AK, Cury V, Jeremias IC, Petroni R, Chausse B, Ariga SK, Herrera AC, Panis C, Lima TM, Souza HP (2015) Tumour Biol

Abstract: Breast cancer is a prevalent neoplastic disease among women worldwide which treatments still present several side effects and resistance. Considering that cancer cells present derangements in their energetic homeostasis, and that peroxisome proliferator-activated receptor- gamma coactivator 1 (PGC-1) is crucial for cellular metabolism and redox signaling, the main objective of this study was to investigate whether there is a relationship between PGC-1 expression, the proliferation of breast cancer cells and the mechanisms involved. We initially assessed PGC-1Ξ² expression in complementary DNA (cDNA) from breast tumor of patients bearing luminal A, luminal B, and HER2-overexpressed and triple negative tumors. Our data showed that PGC-1Ξ² expression is increased in patients bearing HER2-overexpressing tumors as compared to others subtypes. Using quantitative PCR and immunoblotting, we showed that breast cancer cells with HER2-amplification (SKBR-3) have greater expression of PGC-1Ξ² as compared to a non-tumorous breast cell (MCF-10A) and higher proliferation rate. PGC-1Ξ² expression was knocked down with short interfering RNA in HER2-overexpressing cells, and cells decreased proliferation. In these PGC-1Ξ²-inhibited cells, we found increased citrate synthase activity and no marked changes in mitochondrial respiration. Glycolytic pathway was decreased, characterized by lower intracellular lactate levels. In addition, after PGC-1Ξ² knockdown, SKBR-3 cells showed increased reactive oxygen species production, no changes in antioxidant activity, and decreased expression of ERRΞ±, a modulator of metabolism. In conclusion, we show an association of HER2-overexpression and PGC-1Ξ². PGC-1Ξ² knockdown impairs HER2-overexpressing cells proliferation acting on ERRΞ± signaling, metabolism, and redox balance. β€’ Keywords: Breast cancer subtypes, HER2-overexpressing, PGC-1Ξ², Proliferation, Human breast adenocarcinoma SKBR-3 cells


Labels: MiParea: Respiration, Genetic knockout;overexpression, Patients  Pathology: Cancer 

Organism: Human  Tissue;cell: Genital  Preparation: Intact cells 


Coupling state: LEAK, ROUTINE, ETS 

HRR: Oxygraph-2k 

[[additional label::[Epub ahead of print]]], 2016-01 

Cookies help us deliver our services. By using our services, you agree to our use of cookies.